Mythic Therapeutics
PrivateLast Round
VC Round
Dec 24, 2024
Total Funding Raised
$126.5M
Company Overview
Mythic Therapeutics is a biotechnology company that specialized in developing antibody-drug conjugates (ADCs) to deliver chemotherapy directly to tumors, enhancing efficacy while minimizing side effects and toxicity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mythic Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Mythic Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 24, 2024 | ||||
| Series B | Dec 15, 2021 | ||||
| Series A | Aug 13, 2020 |
Mythic Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Refactor Capital | Series B, Series A |
| Perceptive Advisors | Series B |
| Blue Goose Capital | Series B |
| Highside Capital Management | Series B |
| Lifeforce Capital | Series B, Series A |
| Foresite Capital | Series B |
| First Round Capital | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2025
Presenting Phase 1 KisMET-01 study results at ASCO 2025.
Mythic Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Mythic Therapeutics's valuation, stock price, and market status.